Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Immuno-C: Filed IND; expects to start Phase I trial in 25 healthy volunteers, testing dose and measuring how much crosses from gut into the bloodstream

Biomune Systems Inc. (BIMED), Salt

Read the full 55 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE